Ann: BCT signs three-year A$15.9M supply deal with Labcon, page-81

Thanks for stopping by at 4m.

Company is doing very well, progressing with sales and its plan. Plenty on the pipeline, sales growing and solid contracts in place. All in the public domain via press releases.

BCT investors sleep well cause management is executing per their strategy. Share price moving up and down ST after a raising is what the price does, but for long-term investors that does not really matter as long as the business continues to deliver, which it has.

Company is cashed up which takes them to profitability and positive cashflow - all based on existing min order volumes.


It's a fantastic story that will continue to unfold gradually.